product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
DYRK1B (D40D1) Rabbit mAb
catalog :
5672
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D40D1
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation
citations: 4
Published Application/Species/Sample/DilutionReference
  • immunoprecipitation; human; fig 2
  • western blot; human; 1:1000; fig 3
Lee S, Frattini V, Bansal M, Castano A, Sherman D, Hutchinson K, et al. An ID2-dependent mechanism for VHL inactivation in cancer. Nature. 2016;529:172-7 pubmed publisher
Singh R, Dhanyamraju P, Lauth M. DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway. Oncotarget. 2017;8:833-845 pubmed publisher
Gay G, Braun L, Brenier Pinchart M, Vollaire J, Josserand V, Bertini R, et al. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-?-mediated host defenses. J Exp Med. 2016;213:1779-98 pubmed publisher
Zhang Q, Liu S, Zhang Q, Xiong Z, Wang A, Myers L, et al. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment. Prostate. 2014;74:869-79 pubmed publisher
product information
SKU :
5672S
Product-Name :
DYRK1B (D40D1) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, (Mk)
Applications :
Immunoprecipitation
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
70-80
Host :
Rabbit
Target :
Dyrk1B
Primary-Protein :
DYRK1B
Alt-Names :
DYR1B,DYRK1B,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,MIRK,Minibrain-related kinase,Mirk protein kinase,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.